TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS

Abstract Binding of tumour necrosis factor α (TNFα) to its receptor (TNFR1) is critical for both survival and death cellular pathways. TNFα/TNFR1 signalling is complex and tightly regulated at different levels to control cell fate decisions. Previously, we identified TNFR1-d2, an exon 2-spliced tran...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Cécile Rittore, Déborah Méchin, Elodie Sanchez, Léa Marinèche, Vuthy Ea, Stephan Soler, Marion Vereecke, Aude Mallavialle, Eric Richard, Isabelle Duroux-Richard, Florence Apparailly, Isabelle Touitou, Sylvie Grandemange
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/a4e7c6e8c75e4d73b0e1b39d5758f67a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a4e7c6e8c75e4d73b0e1b39d5758f67a
record_format dspace
spelling oai:doaj.org-article:a4e7c6e8c75e4d73b0e1b39d5758f67a2021-12-02T14:21:59ZTNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS10.1038/s41598-021-83539-92045-2322https://doaj.org/article/a4e7c6e8c75e4d73b0e1b39d5758f67a2021-02-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-83539-9https://doaj.org/toc/2045-2322Abstract Binding of tumour necrosis factor α (TNFα) to its receptor (TNFR1) is critical for both survival and death cellular pathways. TNFα/TNFR1 signalling is complex and tightly regulated at different levels to control cell fate decisions. Previously, we identified TNFR1-d2, an exon 2-spliced transcript of TNFRSF1A gene encoding TNFR1, whose splicing may be modulated by polymorphisms associated with inflammatory disorders. Here, we investigated the impact of TNFRSF1A variants involved in TNFR-associated periodic syndrome (TRAPS) on TNFR1-d2 protein expression and activity. We found that TNFR1-d2 could be translated by using an internal translation initiation codon and a de novo internal ribosome entry site (IRES), which resulted in a putative TNFR1 isoform lacking its N-terminal region. The kinetic of assembly of TNFR1-d2 clusters at the cell surface was reduced as compared with full-length TNFR1. Although co-localized with the full-length TNFR1, TNFR1-d2 neither activated nuclear factor (NF)-κB signalling, nor interfered with TNFR1-induced NF-κB activation. Translation of TNFR1-d2 carrying the severe p.(Thr79Met) pathogenic variant (also known as T50M) was initiated at the mutated codon, resulting in an elongated extracellular domain, increased speed to form preassembled clusters in absence of TNFα, and constitutive NF-κB activation. Overall, TNFR1-d2 might reflect the complexity of the TNFR1 signalling pathways and could be involved in TRAPS pathophysiology of patients carrying the p.(Thr79Met) disease-causing variant.Cécile RittoreDéborah MéchinElodie SanchezLéa MarinècheVuthy EaStephan SolerMarion VereeckeAude MallavialleEric RichardIsabelle Duroux-RichardFlorence ApparaillyIsabelle TouitouSylvie GrandemangeNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-16 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Cécile Rittore
Déborah Méchin
Elodie Sanchez
Léa Marinèche
Vuthy Ea
Stephan Soler
Marion Vereecke
Aude Mallavialle
Eric Richard
Isabelle Duroux-Richard
Florence Apparailly
Isabelle Touitou
Sylvie Grandemange
TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS
description Abstract Binding of tumour necrosis factor α (TNFα) to its receptor (TNFR1) is critical for both survival and death cellular pathways. TNFα/TNFR1 signalling is complex and tightly regulated at different levels to control cell fate decisions. Previously, we identified TNFR1-d2, an exon 2-spliced transcript of TNFRSF1A gene encoding TNFR1, whose splicing may be modulated by polymorphisms associated with inflammatory disorders. Here, we investigated the impact of TNFRSF1A variants involved in TNFR-associated periodic syndrome (TRAPS) on TNFR1-d2 protein expression and activity. We found that TNFR1-d2 could be translated by using an internal translation initiation codon and a de novo internal ribosome entry site (IRES), which resulted in a putative TNFR1 isoform lacking its N-terminal region. The kinetic of assembly of TNFR1-d2 clusters at the cell surface was reduced as compared with full-length TNFR1. Although co-localized with the full-length TNFR1, TNFR1-d2 neither activated nuclear factor (NF)-κB signalling, nor interfered with TNFR1-induced NF-κB activation. Translation of TNFR1-d2 carrying the severe p.(Thr79Met) pathogenic variant (also known as T50M) was initiated at the mutated codon, resulting in an elongated extracellular domain, increased speed to form preassembled clusters in absence of TNFα, and constitutive NF-κB activation. Overall, TNFR1-d2 might reflect the complexity of the TNFR1 signalling pathways and could be involved in TRAPS pathophysiology of patients carrying the p.(Thr79Met) disease-causing variant.
format article
author Cécile Rittore
Déborah Méchin
Elodie Sanchez
Léa Marinèche
Vuthy Ea
Stephan Soler
Marion Vereecke
Aude Mallavialle
Eric Richard
Isabelle Duroux-Richard
Florence Apparailly
Isabelle Touitou
Sylvie Grandemange
author_facet Cécile Rittore
Déborah Méchin
Elodie Sanchez
Léa Marinèche
Vuthy Ea
Stephan Soler
Marion Vereecke
Aude Mallavialle
Eric Richard
Isabelle Duroux-Richard
Florence Apparailly
Isabelle Touitou
Sylvie Grandemange
author_sort Cécile Rittore
title TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS
title_short TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS
title_full TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS
title_fullStr TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS
title_full_unstemmed TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS
title_sort tnfr1-d2 carrying the p.(thr79met) pathogenic variant is a potential novel actor of tnfα/tnfr1 signalling regulation in the pathophysiology of traps
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/a4e7c6e8c75e4d73b0e1b39d5758f67a
work_keys_str_mv AT cecilerittore tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT deborahmechin tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT elodiesanchez tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT leamarineche tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT vuthyea tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT stephansoler tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT marionvereecke tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT audemallavialle tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT ericrichard tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT isabelledurouxrichard tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT florenceapparailly tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT isabelletouitou tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
AT sylviegrandemange tnfr1d2carryingthepthr79metpathogenicvariantisapotentialnovelactoroftnfatnfr1signallingregulationinthepathophysiologyoftraps
_version_ 1718391507071795200